Mice are protected from Helicobacter pylori infection by nasal immunization with attenuated Salmonella typhimurium phoPc expressing urease A and B subunits
- PMID: 9453612
- PMCID: PMC113500
- DOI: 10.1128/IAI.66.2.581-586.1998
Mice are protected from Helicobacter pylori infection by nasal immunization with attenuated Salmonella typhimurium phoPc expressing urease A and B subunits
Abstract
Live Salmonella typhimurium phoPc bacteria were tested as mucosal vaccine vectors to deliver Helicobacter pylori antigens. The genes encoding the A and B subunits of H. pylori urease were introduced into S. typhimurium phoPc and expressed under the control of a constitutive tac promoter (tac-ureAB) or a two-phase T7 expression system (cT7-ureAB). Both recombinant Salmonella strains expressed the two urease subunits in vitro and were used to nasally immunize BALB/c mice. The plasmid carrying cT7-ureAB was stably inherited by bacteria growing or persisting in the spleen, lungs, mesenteric or cervical lymph nodes, and Peyer's patches of immunized mice, while the plasmid carrying tac-ureAB was rapidly lost. Spleen and Peyer's patch CD4+ lymphocytes from mice immunized with S. typhimurium phopc cT7-ureAB proliferated in vitro in response to urease, whereas cells from mice given S. typhimurium phoPc alone did not. Splenic CD4+ cells from mice immunized with phoPc cT7-ureAB secreted gamma interferon and interleukin 10, while Peyer's patch CD4+ cells did not secrete either cytokine. Specific H. pylori anti-urease immunoglobulin G1 (IgG1) and IgG2A antibodies were detected following immunization, confirming that both Th1- and Th2-type immune responses were generated by the live vaccine. Sixty percent of the mice (9 of 15) immunized with S. typhimurium phoPc cT7-ureAB were found to be resistant to infection by H. pylori, while all mice immunized with phoPc tac-ureAB (15 of 15) or phoPc (15 of 15) were infected. Our data demonstrate that H. pylori urease delivered nasally by using a vaccine strain of S. typhimurium can trigger Th1- and Th2-type responses and induce protective immunity against Helicobacter infection.
Figures




Similar articles
-
Attenuated Salmonella enterica serovar Typhi expressing urease effectively immunizes mice against Helicobacter pylori challenge as part of a heterologous mucosal priming-parenteral boosting vaccination regimen.Infect Immun. 2002 Sep;70(9):5096-106. doi: 10.1128/IAI.70.9.5096-5106.2002. Infect Immun. 2002. PMID: 12183559 Free PMC article.
-
Oral immunization of mice with vaccine of attenuated Salmonella typhimurium expressing Helicobacter pylori urease B subunit.Biomed Environ Sci. 2005 Dec;18(6):411-8. Biomed Environ Sci. 2005. PMID: 16544523
-
Oral immunization of mice with attenuated Salmonella typhimurium expressing Helicobacter pylori urease B subunit.Chin Med J (Engl). 2002 Oct;115(10):1513-6. Chin Med J (Engl). 2002. PMID: 12490099
-
Systemic immune responses to oral administration of recombinant attenuated Salmonella typhimurium expressing Helicobacter pylori urease in mice.World J Gastroenterol. 2005 Apr 14;11(14):2154-6. doi: 10.3748/wjg.v11.i14.2154. World J Gastroenterol. 2005. PMID: 15810083 Free PMC article.
-
Hybrid hepatitis B virus core antigen as a vaccine carrier moiety. II. Expression in avirulent Salmonella spp. for mucosal immunization.Adv Exp Med Biol. 1996;397:15-21. Adv Exp Med Biol. 1996. PMID: 8718577 Review.
Cited by
-
Pilot study of phoP/phoQ-deleted Salmonella enterica serovar typhimurium expressing Helicobacter pylori urease in adult volunteers.Infect Immun. 2000 Apr;68(4):2135-41. doi: 10.1128/IAI.68.4.2135-2141.2000. Infect Immun. 2000. PMID: 10722611 Free PMC article. Clinical Trial.
-
In vivo visualization of bacterial colonization, antigen expression, and specific T-cell induction following oral administration of live recombinant Salmonella enterica serovar Typhimurium.Infect Immun. 2001 Jul;69(7):4618-26. doi: 10.1128/IAI.69.7.4618-4626.2001. Infect Immun. 2001. PMID: 11402006 Free PMC article.
-
Increased antigen specific T cell numbers in the absence of altered migration or division rates as a result of mucosal cholera toxin administration.PLoS One. 2013;8(3):e59934. doi: 10.1371/journal.pone.0059934. Epub 2013 Mar 27. PLoS One. 2013. PMID: 23544110 Free PMC article.
-
Challenge model for Helicobacter pylori infection in human volunteers.Gut. 2004 Sep;53(9):1235-43. doi: 10.1136/gut.2003.037499. Gut. 2004. PMID: 15306577 Free PMC article.
-
Vaccination against Bacterial Infections: Challenges, Progress, and New Approaches with a Focus on Intracellular Bacteria.Vaccines (Basel). 2022 May 10;10(5):751. doi: 10.3390/vaccines10050751. Vaccines (Basel). 2022. PMID: 35632507 Free PMC article. Review.
References
-
- Abrams J S, Roncarolo M G, Yssel H, Andersson U, Gleich G J, Silver J E. Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples. Immunol Rev. 1992;127:5–24. - PubMed
-
- Corthésy-Theulaz I, Porta N, Glauser M, Saraga E, Vaney A C, Haas R, Kraehenbuhl J P, Blum A L, Michetti P. Oral immunization with Helicobacter pylori urease as a treatment against Helicobacter infection. Gastroenterology. 1995;109:115–121. - PubMed
-
- Cuenca R, Blanchard T, Lee C K, Monath T P, Redline R, Nedrud J G, Czinn S J. Therapeutic immunization against Helicobacter mustelae in naturally infected ferrets. Gastroenterology. 1995;108:A78. - PubMed
-
- Curtiss R D, Kelly S M, Hassan J O. Live oral avirulent Salmonella vaccines. Vet Microbiol. 1993;37:397–405. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials